Oxford College to check COVID vaccine response in youngsters | Coronavirus pandemic Information

Approximately 300 volunteers are expected to take part in the first study of the immune response in children to the AstraZeneca vaccine.

Oxford University has started a study to evaluate the safety and immune response of the COVID-19 vaccine, which it first developed in children with AstraZeneca.

The new interim study will determine whether the vaccine is effective for people between the ages of six and 17, according to a statement from the university on Saturday.

About 300 volunteers will be enrolled and first vaccinations are expected this month, Oxford said.

Up to 240 subjects will receive the vaccine while the rest will receive a control drug.

Andrew Pollard, Professor of Pediatric Infection and Immunity and Principal Investigator for the Oxford Vaccine Study, said, “While most children are relatively unaffected by coronavirus and are unlikely to develop the infection, it is important to establish the safety and immune response to the vaccine in the case Children and adolescents, as some children may benefit from vaccination. “

The Oxford-AstraZeneca double-dose vaccine has been named “Vaccine for the World” because it is cheaper and easier to distribute than some of its competitors.

AstraZeneca aims to produce three billion cans this year and to produce more than 200 million cans per month by April.